Related references
Note: Only part of the references are listed.Phase I study of nelfinavir in liposarcoma
Janet Pan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer
Min Guan et al.
FEBS JOURNAL (2012)
Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
Joong Sup Shim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Functional Hierarchy of Herpes Simplex Virus 1 Viral Glycoproteins in Cytoplasmic Virion Envelopment and Egress
Dmitry V. Chouljenko et al.
JOURNAL OF VIROLOGY (2012)
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
Jocelyne Piret et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The HIV Protease Inhibitor Nelfinavir Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication In Vitro
Soren Gantt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Nelfinavir Induces Liposarcoma Apoptosis through Inhibition of Regulated Intramembrane Proteolysis of SREBP-1 and ATF6
Min Guan et al.
CLINICAL CANCER RESEARCH (2011)
Nuclear Envelope Breakdown Can Substitute for Primary Envelopment-Mediated Nuclear Egress of Herpesviruses
Barbara G. Klupp et al.
JOURNAL OF VIROLOGY (2011)
Herpes Simplex Virus Glycoproteins gB and gD Function in a Redundant Fashion To Promote Secondary Envelopment
David C. Johnson et al.
JOURNAL OF VIROLOGY (2011)
A Domain in the Herpes Simplex Virus 1 Triplex Protein VP23 Is Essential for Closure of Capsid Shells into Icosahedral Structures
Hong Seok Kim et al.
JOURNAL OF VIROLOGY (2011)
Differing Roles of Inner Tegument Proteins pUL36 and pUL37 during Entry of Herpes Simplex Virus Type 1
Ashley P. E. Roberts et al.
JOURNAL OF VIROLOGY (2009)
Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy
Joell J. Gills et al.
AUTOPHAGY (2008)
Localization of Herpes Simplex Virus Type 1 UL37 in the Golgi Complex Requires UL36 but Not Capsid Structures
Prashant Desai et al.
JOURNAL OF VIROLOGY (2008)
Repositioning HIV protease inhibitors as cancer therapeutics
Wendy B. Bernstein et al.
CURRENT OPINION IN HIV AND AIDS (2008)
Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane
Aaron Farnsworth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest
Wei Jiang et al.
CANCER RESEARCH (2007)
Herpes simplex virus gE/gI must accumulate in the trans-golgi network at early times and then redistribute to cell junctions to promote cell-cell spread
A Farnsworth et al.
JOURNAL OF VIROLOGY (2006)
Herpes simplex virus type 1 Capsids transit by the trans-golgi network, where viral glycoproteins accumulate independently of capsid egress
S Turcotte et al.
JOURNAL OF VIROLOGY (2005)
Essential function of the pseudorabies virus UL36 gene product is independent of its interaction with the UL37 protein
W Fuchs et al.
JOURNAL OF VIROLOGY (2004)
Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation
M Caron et al.
AIDS (2003)
Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm
A Farnsworth et al.
JOURNAL OF VIROLOGY (2003)
Mutation of single hydrophobic residue I27, L35, F39, L58, L65, L67, or L71 in the N terminus of VP5 abolishes interaction with the scaffold protein and prevents closure of herpes simplex virus type 1 capsid shells
JN Walters et al.
JOURNAL OF VIROLOGY (2003)
Transferred herpes simplex virus immunity after stem-cell transplantation: Clinical implications
WG Nichols et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
A null mutation in the gene encoding the herpes simplex virus type 1 UL37 polypeptide abrogates virus maturation
P Desai et al.
JOURNAL OF VIROLOGY (2001)
A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1
M Schmidtke et al.
JOURNAL OF VIROLOGICAL METHODS (2001)
A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells
PJ Desai
JOURNAL OF VIROLOGY (2000)
Evidence that herpes simplex virus VP16 is required for viral egress downstream of the initial envelopment event
KL Mossman et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
